OTC Switch Public Policy, Science Issues Workshop Proposed
This article was originally published in The Tan Sheet
Executive Summary
The idea of a public workshop to address certain issues related to the Rx-to-OTC switch process was generally supported by industry representatives and FDAers at a switch summit held by the Consumer Healthcare Products Association in Washington, D.C. July 16.